gracecastuc081_lung_which patients send for molecular testing
Published 11 years ago • 13 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
2:41
lung cancer video library - evolving standards for molecular testing in advanced nsclc
-
4:11
molecular testing: liquid vs. tissue, and insurance coverage - lung cancer onctalk 2022
-
3:32
gracecastuc100_lung_drs. camidge and langer on which patients send molecular marker testing
-
2:18
gracecastuc-045_lung_which lung cancer patients should we be doing molecular marker testing for?
-
1:59:57
grace - global resource for advancing cancer education live stream
-
4:10
grace targeted therapies lung cancer 2021 - should patients with tumor removed get molecular testing
-
5:16
gracecastuc 126 lung_is it possible to test for biomarkers on a national scale?
-
28:22
gracecast-088_lung-cancer_challenging cases in lung cancer: acquired resistance to egfr tki therapy
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
1:45
gracecastuc-048_lung_what molecular markers do you prioritize for adv. nsclc, and who to test?
-
3:56
preferential timing for molecular testing in nsclc
-
17:28
gracecast-098_lung-cancer_mm in lc pt 3: who to test and what to test for -- panel discussion
-
2:58
gracecastuc-068_lung_dr. oxnard on what molecular markers to test for in advanced nsclc
-
16:39
gracecast-067_lung-cancer_expert round table - nsclc molecular markers case 3
-
2:35
gracecastuc-028_lung_dr. goldberg - pros & cons of molecular testing with delays & rebiopsy
-
6:32
grace targeted therapies in lung cancer 2021 - diagnosis and testing: what tests are relevant
-
6:11
gracecastuc-012_lung_the more you seek, the more you find
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
2:01
should we use dna or rna for ngs? - 2022 program: targeted therapies forum